Dimov I, et al. Glioblastoma multiforme stem cells. ScientificWorldJournal. 2011;11:930–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maghrouni A, et al. Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions. Int Immunopharmacol. 2021;93: 107403.

Article  CAS  PubMed  Google Scholar 

Afshari AR, et al. Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS). EXCLI J. 2019;18:576–90.

PubMed  PubMed Central  Google Scholar 

Afshari AR, et al. Effects of statins on brain tumors: a review. Semin Cancer Biol. 2020;73:116.

Article  PubMed  Google Scholar 

Afshari AR, Mollazadeh H, Sahebkar A. Minocycline in treating glioblastoma multiforme: far beyond a conventional antibiotic. J Oncol. 2020;2020:8659802.

Article  PubMed  PubMed Central  Google Scholar 

Soukhtanloo M, et al. Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway. Pharmacol Rep. 2020;72(2):285–95.

Article  PubMed  Google Scholar 

Afshari AR, et al. Protective role of natural products in glioblastoma multiforme: a focus on nitric oxide pathway. Curr Med Chem. 2021;28(2):377–400.

Article  CAS  PubMed  Google Scholar 

Ng QS, et al. Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67(5):1375–80.

Article  CAS  PubMed  Google Scholar 

Pettit GR, et al. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs. Anticancer Drug Des. 1995;10(4):299–309.

CAS  PubMed  Google Scholar 

Zhao D, et al. Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. Faseb j. 2008;22(7):2445–51.

Article  CAS  PubMed  Google Scholar 

Nik ME, et al. Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. J Cell Physiol. 2019;234:14721.

Article  CAS  PubMed  Google Scholar 

Qin H, et al. PI3Kgamma inhibitor attenuates immunosuppressive effect of Poly(l-Glutamic Acid)-combretastatin A4 conjugate in metastatic breast cancer. Adv Sci (Weinh). 2019;6(12):1900327.

Article  PubMed  Google Scholar 

Zhang C, et al. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway. Cell Physiol Biochem. 2015;35(2):419–32.

Article  CAS  PubMed  Google Scholar 

Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 1999;43(Suppl):S42-51.

Article  CAS  PubMed  Google Scholar 

Zhang S, et al. Autophagy- and MMP-2/9-mediated reduction and redistribution of ZO-1 contribute to hyperglycemia-increased blood-brain barrier permeability during early reperfusion in stroke. Neuroscience. 2018;377:126–37.

Article  CAS  PubMed  Google Scholar 

Liu Y, et al. Fucoxanthin activates apoptosis via inhibition of PI3K/Akt/mTOR pathway and suppresses invasion and migration by restriction of p38-MMP-2/9 pathway in human glioblastoma cells. Neurochem Res. 2016;41(10):2728–51.

Article  CAS  PubMed  Google Scholar 

Chen G, et al. Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway in vitro. J Pharmacol Sci. 2017;134(1):59–67.

Article  CAS  PubMed  Google Scholar 

Rodriguez LG, Wu X, Guan JL. Wound-healing assay. Methods Mol Biol. 2005;294:23–9.

PubMed  Google Scholar 

Vandooren J, et al. Zymography methods for visualizing hydrolytic enzymes. Nat Methods. 2013;10(3):211–20.

Article  CAS  PubMed  Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.

Article  CAS  PubMed  Google Scholar 

Mohtashami E, et al. The current state of potential therapeutic modalities for glioblastoma multiforme: a clinical review. Curr Drug Metab. 2020;21(8):564–78.

Article  CAS  PubMed  Google Scholar 

Sherbet GV. Combretastatin analogues in cancer biology: A prospective view. J Cell Biochem. 2020;121(3):2127–38.

Article  CAS  PubMed  Google Scholar 

Nathan P, et al. Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. Clin Cancer Res. 2012;18(12):3428–39.

Article  CAS  PubMed  Google Scholar 

Kamal A, et al. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents. Bioorg Med Chem Lett. 2016;26(12):2957–64.

Article  CAS  PubMed  Google Scholar 

Yan J, et al. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells. Biochem Pharmacol. 2015;97(1):51–61.

Article  CAS  PubMed  Google Scholar 

Tian J, et al. Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells. Chem Biol Interact. 2020;327: 109184.

Article  CAS  PubMed  Google Scholar 

Kanthou C, et al. The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death. Am J Pathol. 2004;165(4):1401–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patterson JC, et al. ROS and oxidative stress are elevated in mitosis during asynchronous cell cycle progression and are exacerbated by mitotic arrest. Cell Syst. 2019;8(2):163-167.e2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karimi Roshan M, et al. Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie. 2019;165:229–34.

Article  CAS  PubMed  Google Scholar 

Jalili-Nik M, et al. Cytotoxic effects of ferula latisecta on human glioma U87 cells. Drug Res (Stuttg). 2019;69(12):665–70.

Article  CAS  PubMed  Google Scholar 

Choe G, et al. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res. 2002;8(9):2894–901.

CAS  PubMed  Google Scholar 

Wang C, et al. Effect of matrix metalloproteinase-mediated matrix degradation on glioblastoma cell behavior in 3D PEG-based hydrogels. J Biomed Mater Res A. 2017;105(3):770–8.

Article  CAS  PubMed  Google Scholar 

Sun LC, et al. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett. 2007;246(1–2):157–66.

Article  CAS  PubMed  Google Scholar 

Mirzavi F, et al. Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model. Int J Pharm. 2022;613: 121396.

Article  CAS  PubMed  Google Scholar 

Gloushankova NA, Rubtsova SN, Zhitnyak IY. Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue Barriers. 2017;5(3): e1356900.

Article  PubMed  PubMed Central  Google Scholar 

Lu Y, et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate. 2006;66(12):1311–8.

Article  CAS  PubMed  Google Scholar 

Dagouassat M, et al. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. Int J Cancer. 2010;126(5):1095–108.

CAS  PubMed  Google Scholar 

Dwyer RM, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res. 2007;13(17):5020–7.

Article  CAS  PubMed  Google Scholar 

Dwyer J, et al. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS ONE. 2012;7(9): e45562.